Your session is about to expire
← Back to Search
Dapivirine + Levonorgestrel Vaginal Rings for Bleeding, Pharmacokinetics, and Safety Concerns
Study Summary
This trial is testing two different formulations of a vaginal ring for their pharmacokinetics, or how the body processes the drug. The trial is double-blind, meaning that neither the participants nor the researchers know who is receiving which formulation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I'm sorry, but it seems like the criterion you provided is incomplete. Could you please provide the full criterion so that I can rewrite it for you?You consistently and correctly use male condoms during sexual activity.You have not used any drugs by injecting them into your body in the past year for non-medical reasons.You have taken medication to prevent getting HIV in the past 3 months.You have a history of frequently getting yeast or bacterial infections in your vagina.You are currently taking or planning to take certain medications like antibiotics or corticosteroids that may interfere with the effectiveness of levonorgestrel.
- Group 1: IPM Ring-105
- Group 2: IPM Ring-106.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the protocol for this research encompass individuals of advanced age?
"This trial is restricted to individuals between 18 and 45 years of age. Separately, there are 65 studies for minors and 359 studies targeting elderly citizens."
Are there any open slots available for this research trial?
"According to clinicaltrials.gov, the enrollment period for this trial has closed since June 21st 2022; however there are still 447 other medical studies actively seeking patients. The study was initially posted on June 1st of 2022."
What are the prerequisites for participating in this experiment?
"This medical research is seeking 40 individuals aged between 18 and 45, who are displaying symptoms of haemorrhage. These potential participants must also meet the following criteria: female assigned gender at birth (exception given to those on a female-male transition therapy in last 90 days), abstention from any vaginal insertion/intercourse for day prior to enrollment visit, contact information provided; availability for all visits adhering with study procedures and requirements, non-hormonal intrauterine device inserted over 3 months ago."
Share this study with friends
Copy Link
Messenger